Proteasomal degradation of tyrosine hydroxylase and neurodegeneration

Journal of Neurochemistry

Volumn 120, Issue 2, 2012, Pages 199-201

  Nakashima, Akira ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; CYCLIN DEPENDENT KINASE 5; DOPAMINE; GLYCOPROTEIN GP 130; LEUKEMIA INHIBITORY FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEASOME; TYROSINE 3 MONOOXYGENASE; UBIQUITIN;

AMINO TERMINAL SEQUENCE; CATECHOLAMINE NERVE CELL; CYTOKINE PRODUCTION; DOPAMINERGIC NERVE CELL; DOWN REGULATION; EDITORIAL; ENZYME ACTIVATION; HEART INFARCTION; NERVE DEGENERATION; NERVE FIBER; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; SYMPATHETIC NERVE CELL;

ANIMALS; CYTOKINE RECEPTOR GP130; FEMALE; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEURONS; PREGNANCY; PROTEASOME ENDOPEPTIDASE COMPLEX; TYROSINE 3-MONOOXYGENASE;

EID: 84055172786     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07562.x     Document Type: Editorial

References (12)

1. Døskeland A. P., and, Flatmark T., (2002) Ubiquitination of soluble and membrane-bound tyrosine hydroxylase and degradation of the soluble form. Eur. J. Biochem. 269, 1561-1569. (Pubitemid 34227098)
2. Dunkley P. R., Bobrovskaya L., Graham M. E., von Nagy-Felsobuki E. I., and, Dickson P. W., (2004) Tyrosine hydroxylase phosphorylation: regulation and consequences. J. Neurochem. 91, 1025-1043. (Pubitemid 39587442)
3. Goldstein D. S., Holmes C., Cannon R. O., III, Eisenhofer G., and, Kopin I. J., (1997) Sympathetic cardioneuropathy in dysautonomias. N. Engl. J. Med. 336, 696-702. (Pubitemid 27102684)
4. Lopez Verrilli M. A., Pirola C. J., Pascual M. M., Dominici F. P., Turyn D., and, Gironacci M. M., (2009) Angiotensin-(1-7) through AT receptors mediates tyrosine hydroxylase degradation via the ubiquitin-proteasome pathway. J. Neurochem. 109, 326-335.
5. McNaught K. S., Jackson T., JnoBaptiste R., Kapustin A., and, Olanow C. W., (2006) Proteasomal dysfunction in sporadic Parkinson's disease. Neurology 66, S37-S49.
6. Moy L. Y., and, Tsai L. H., (2004) Cyclin-dependent kinase 5 phosphorylates serine 31 of tyrosine hydroxylase and regulates its stability. J. Biol. Chem. 279, 54487-54493. (Pubitemid 40053189)
7. Nakashima A., Hayashi N., Kaneko Y. S., Mori K., Sabban E. L., Nagatsu T., and, Ota A., (2007) RNAi of 14-3-3eta protein increases intracellular stability of tyrosine hydroxylase. Biochem. Biophys. Res. Commun. 363, 817-821. (Pubitemid 47513703)
8. Obsilova V., Nedbalkova E., Silhan J., Boura E., Herman P., Vecer J., Sulc M., Teisinger J., Dyda F., and, Obsil T., (2008) The 14-3-3 protein affects the conformation of the regulatory domain of human tyrosine hydroxylase. Biochemistry 47, 1768-1777. (Pubitemid 351231226)
9. Sato S., Chiba T., Sakata E., Kato K., Mizuno Y., Hattori N., and, Tanaka K., (2006) 14-3-3I· is a novel regulator of parkin ubiquitin ligase. EMBO J. 25, 211-221. (Pubitemid 43077309)
10. Shi X., and, Habecker B. A., (2011) gp130 cytokines stimulate proteasomal degradation of tyrosine hydroxylase via extracellular signal regulated kinases 1 & 2. J. Neurochem 120, 239-247.
11. Sorokina E. M., Feinstein S. I., Zhou S., and, Fisher A. B., (2011) Intracellular targeting of peroxiredoxin 6 to lysosomal organelles requires MAPK activity and binding to 14-3-3Iμ. Am. J. Physiol. Cell Physiol. 300, C1430-C1441.
12. Xu J., Kao S. Y., Lee F. J., Song W., Jin L. W., and, Yankner B. A., (2002) Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat. Med. 8, 600-606. (Pubitemid 34633438)